Geron | GERN - Cost Of Sales


Geron reported $1.69M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Amgen USD 1.87B 271M Jun/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Cassava Sciences USD 3.96M 1.16M Sep/2025
Cytokinetics USD 5.59M 5.43M Jun/2026
Exelixis USD 20.66M 704K Jun/2026
Genmab DKK 84M 19M Jun/2026
Geron USD 1.69M 386K Mar/2026
Gilead Sciences USD 1000M 445M Jun/2026
Incyte USD 104.96M 457K Jun/2026
MacroGenics USD 9.53M 585K Mar/2026
Novartis USD 3.71B 251M Jun/2026
Novavax USD 22.1M 608K Dec/2025